Loading Please wait, logging in.
Join ALFA Member Login RSS Feed
Tagline Image
Bookmark and Share  

Chronic Stress May Lead to Alzheimer’s Disease, Study Says

New research has found that stress-induced hormones produced by the brain can increase an individual’s risk of developing Alzheimer’s disease and accelerate the development of Alzheimer’s in individuals already suffering from the disease.

While previous reports have linked elevated levels of stress with an increased risk in an individual developing dementia, this study is the first to discover the precise mechanism that causes stress-induced Alzheimer’s disease.

When the brain is stressed, it produces steroids that can inhibit general brain activity. One of such steroids, allopregnanolon, was the subject of a study led by Swedish researcher Sara K. Bengtsson.

In order to test how and why stress can lead to dementia later in life, the research team conducted a laboratory experiment on mice genetically predisposed to developing Alzheimer’s disease. The mice were treated chronically with elevated allopregnanolone levels, comparable to those caused by mild stress. After a period of no steroid treatment, the mice were tested for learning and memory.

The mice with elevated levels of the stress steroid experienced impaired memory and learning in the earliest stages of Alzheimer’s development, when they normally would not display these symptoms. The brains of the mice also displayed higher levels of beta-amyloids, proteins that form plaques between nerve cells in the brains of individuals with Alzheimer’s disease. The researchers noted that a similar acceleration of Alzheimer's disease in humans due to chronic stress could mean the difference between living independently and requiring professional care.

Bengtsson concluded that allopregnanolone is an important link in the mechanism behind stress-induced Alzheimer’s disease, but that further studies would be required to uncover the full extent of its influence.

Read the study abstract: Stress Steroids as Accelerators of Alzheimer's Disease- Effects of Chronically Elevated Levels of Allopregnanolone in Transgenic AD Models.



Suggested Articles:

4/27/2016
cheatsheet, Federal Agency Activity, Health and Wellness, Managed Risk, Memory Care Best Practices and Research, Memory Care Education
The Dementia Friendly America program entered the national stage in July when it was announced at the 2015 White House Conference on Aging. DFA cre...
4/20/2016
Senior Living Executive magazine spoke with geriatrician and memory care expert Dr. G. Allen Power about his philosophies on getting older and the rol...
4/14/2016
End of Life, Health and Wellness, Medication Management, Memory Care Best Practices and Research, Memory Care Education
The Administration for Community Living has developed a three-part set of materials on medications and the aging brain, available by clicking on the B...
4/6/2016
Many relatives and friends providing financial support or care to individuals with dementia are dipping into their retirement savings and sold assets ...
3/1/2016
Exercise has been touted for its many health benefits, but a new study shows it can also help prevent or slow Alzheimer’s disease.
03/19/2013


Additional Resources